Sunrise Sessions

Sunrise Sessions

Time: 7:00-8:00am

Sunrise Session Chairs:

Sunday, July 1 (Concurrent Sessions)

WHO 2016: Where Do We Go From Here?

Presenters:

Topics:

  • The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMACT), progress in relation to pediatric low grade glioma and vision for the future.
  • Epilepsy-associated neuroepithelial tumors in the 2016 WHO classification and directions for the future.

Emerging Neuroimaging Techniques for CNS Tumors

Presenters:

Topics:

  • Blood Vessel Wall Imaging
  • Hybrid PET/MR in pediatric glioma and advanced MRI for pediatric brain tumors

The Yin and Yang of Cancer Genetics :  Cancer Predisposition in the Genomic Era

Presenters:

Topics:

  • Introduction: A new era of cancer genomics and its effect on cancer predisposition
  • The enlarging spectrum of SWI/SNF germline defects and cancer predisposition
  • How medulloblastoma genomics can help unveil cancer predisposition
  • Hypermutation in cancer: Insights from tumor analysis can be traced to the germline

Monday, July 2 (Concurrent Sessions)

Intraoperative MRI: Clinical Advance or Marketing Tool

Presenters:

Topics:

  • Limited Utility of the IMR Polestar System in Pediatric Neurosurgical Oncology
  • Application of iMRI in the modern pediatric neurosurgical oncology facility

Animal Models for Preclinical Studies in Pediatric CNS Tumors

Presenters:

Topics:

  • Attempts to model embryonal tumors with multilayered rosettes
  • Genetically engineered mouse models of craniopharyngioma
  • Myc alone drives Group 3 medulloblastoma

Using Molecular Diagnostics in Developing Therapy for Pediatric CNS Tumors

Presenters:     

Topics:

  • CNS – Targeted Agent Prediction method in clinical decision making
  • Baylor Advancing Sequencing in Childhood Cancer Care (BASIC3)
  • Molecular profiling for the development of new therapies and translation to the clinic.